TSW
BHST

Thompson Siegel & Walmsley’s BioHarvest Sciences BHST Stock Holding History

Thompson Siegel & Walmsley’s Portfolio BHST Stock Details BHST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Sell
364,008
-22,751
-6% -$86.8K 0.02% 323
2026
Q1 		$1.68M Buy
386,759
+12,042
+3% +$56.7K 0.03% 293
2025
Q4 		$1.95M Buy
+374,717
New +$3M 0.03% 276

Other funds holding BHST

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
TNA
True North Advisors Dallas, Texas $1.05B AUM 22.99% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Thompson Siegel & Walmsley's BHST Position: Q2 2026 in Review

Thompson Siegel & Walmsley reduced its BioHarvest Sciences (BHST) stake by 5.9% in Q2 2026, selling an estimated $86.8K and leaving 364,008 shares worth $1.04M. The position accounts for 0.02% of the portfolio, ranked #323.

Thompson Siegel & Walmsley first reported a position in BHST in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.95M in Q4 2025. 19 funds tracked by Wall St. Rank hold BHST as of Q2 2026.

  • Thompson Siegel & Walmsley held 364,008 shares of BioHarvest Sciences worth $1.04M as of Q2 2026.
  • Thompson Siegel & Walmsley sold 22,751 BioHarvest Sciences shares in Q2 2026, an estimated $86.8K.
  • BioHarvest Sciences made up 0.02% of Thompson Siegel & Walmsley's portfolio in Q2 2026, its #323 holding.
  • Thompson Siegel & Walmsley first reported a position in BioHarvest Sciences in Q4 2025 and has held it in 3 quarters since.
  • Thompson Siegel & Walmsley's BioHarvest Sciences position peaked at $1.95M in Q4 2025.
  • 19 funds tracked by Wall St. Rank held BioHarvest Sciences as of Q2 2026.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2026, filed 11 Aug 2026.